Avoiding exploitation in multinational covid-19 vaccine trialsLow and middle income countries must benefit, not just participate
No takes yet. Share an insight, caveat, or question.
Iyer et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: